PRONEXUS (7893) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
15 Oct, 2026Executive summary
9M FY2026 revenue rose 5.3% YoY to ¥25,894 million, driven by higher outsourcing and event-support demand and JBA Holdings consolidation.
Operating profit increased 1.7% to ¥3,316 million despite higher personnel, system-upgrade, and other costs.
Profit before tax fell 27.9% to ¥3,397 million and profit attributable to owners of parent fell 29.5% to ¥2,259 million, reflecting the prior-year ¥1,411 million investment-sale gain.
Financial highlights
Gross profit rose 7.0% to ¥10,069 million; cost of sales ratio improved 0.6 percentage points to 61.1%.
Cost of sales increased 4.2% to ¥15,825 million; SG&A rose 9.1% to ¥6,795 million, mainly due to higher personnel costs.
EPS fell to ¥88.66 from ¥125.67; operating margin was 12.8% versus 13.3%, and attributable profit margin was 8.7% versus 13.0%.
Total assets were ¥38,289 million, equity was ¥25,457 million, and the equity ratio was 64.6% at Dec. 31, 2025.
Outlook and guidance
FY2026 forecast: revenue ¥31,800 million, operating profit and profit before tax ¥2,800 million each, and attributable profit ¥1,800 million.
9M revenue and operating profit were 81.4% and 118.4% of their respective full-year forecasts; no forecast revision was made.
FY2026 annual dividend forecast is ¥38 per share, comprising a ¥36 ordinary dividend and ¥2 commemorative dividend; payout-ratio standard is 50% or higher.
Latest events from PRONEXUS
- Acquisition-led event growth lifted 9M revenue 13% and operating profit 26%.7893
Q3 2024 - H1 growth was strong, but full-year guidance stayed unchanged amid execution uncertainty.7893
Q2 2024 - Record FY24 revenue and event growth underpin higher FY25 targets.7893
Q4 2024 - Events-led growth lifted Q1 revenue 7.5%, while profit rose 7.5%.7893
Q1 2024 - Flat revenue, lower costs and an investment-sale gain drove higher Q1 profit.7893
Q1 2025 - H1 profit rose, including an investment-sale gain; FY2025 guidance was unchanged.7893
Q2 2025 - Revenue and operating profit rose; a one-off investment gain boosted net profit.7893
Q3 2025 - Record revenue and higher core profit contrasted with impairment-hit earnings.7893
Q4 2025 - Revenue rose 3%, while operating profit fell 4.6% and net profit fell 33.9%.7893
Q2 2026